Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia

NCT00613457 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2039

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: dexamethasone
DRUG: asparaginase
DRUG: Asparaginase
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: daunorubicin
DRUG: doxorubicin
DRUG: Etoposide
DRUG: Ifosfamide
DRUG: mercaptopurine
DRUG: Methotrexate
DRUG: prednisone
DRUG: thioguanine
DRUG: Vincristine
DRUG: Vindesine

Sponsor

Associazione Italiana Ematologia Oncologia Pediatrica